1 Projects | 1 Researchers | $1,190,392 Invested
2021
Wave Life Sciences
Anne-Marie Li-Kwai-Cheung
A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 1b/2a Study of WVE-004 Administered Intrathecally to Patients with C9orf72-associated Amyotrophic Lateral Sclerosis (ALS) or Frontotemporal Dementia (FTD)